US FDA approves Takeda’s Gammagard Liquid to treat adults with CIDP
Takeda has received the US Food and Drug Administration (FDA) approval for Gammagard Liquid [Immune Globulin Infusion (Human) 10% solution] to treat adults chronic inflammatory demyelinating polyneuropathy (CIDP).